Reducing and treating infection is a significant global challenge. Bacteria, fungi and super-bugs that are resistant to current treatments are impacting individuals’ health on a daily basis, and in many cases are life threatening. The cost to treat these infections continues to mount with no end in sight.
Prevent-Plus, LLC was founded to acquire the intellectual property rights of Medpak, LLC (“Medpak”). On April 12, 2016 the asset acquisition was completed. Among the assets acquired were the approval from the United States Food and Drug Administration (“FDA”) to use Elastic Skin Liquid Bandage for certain specified applications (FDA (510)k No. K032948), United States Patent numbers 6909027 and 7119246 of the Elastic Skin Liquid Bandage, which has been rebranded as DuraDerm®.
The goal of Prevent-Plus is to help prevent infections globally by utilizing and expanding upon the intellectual property that Prevent-Plus, LLC, acquired from Medpak.
Prevent-Plus, LLC. is a company comprised of key strategic partners, including an esteemed physician, chemical engineer, Pharm. D., lawyer, hospital management, and pharmaceutical experts.